BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38301499)

  • 21. Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
    Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
    J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients.
    Jing H; Xiuhong W; Ying Y; Zhenrong L; Xiyun C; Deping L; Changmei S; Qi W; Tao P; Yiyun P
    World J Surg Oncol; 2021 Jul; 19(1):209. PubMed ID: 34253208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
    Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
    Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
    Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic Versus Open Radical Hysterectomy in Women With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: A Single-institution Experience of Surgical and Oncologic Outcomes.
    Zanagnolo V; Minig L; Cárdenas-Rebollo JM; Achilarre MT; Garbi A; Patrono MG; Colombo N; Maggioni A
    J Minim Invasive Gynecol; 2016; 23(6):909-16. PubMed ID: 27158094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
    Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J
    Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective comparison of laparoscopic versus open radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer.
    Cai J; Yang L; Dong W; Wang H; Xiong Z; Wang Z
    Int J Gynaecol Obstet; 2016 Jan; 132(1):29-33. PubMed ID: 26434669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.
    Sakuragi N; Kato T; Shimada C; Kaneuchi M; Todo Y; Mitamura T; Takeda M; Kudo M; Murakami G; Watari H
    JAMA Netw Open; 2020 May; 3(5):e204307. PubMed ID: 32379332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clusterin expression inversely correlates with chemosensitivity and predicts poor survival in patients with locally advanced cervical cancer treated with cisplatin-based neoadjuvant chemotherapy and radical hysterectomy.
    Watari H; Kanuma T; Ohta Y; Hassan MK; Mitamura T; Hosaka M; Minegishi T; Sakuragi N
    Pathol Oncol Res; 2010 Sep; 16(3):345-52. PubMed ID: 20058210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
    Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
    Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of p16 and Ki-67 with Risk of Recurrence in Previously Treated Cervical High-Grade Squamous Intraepithelial Lesions.
    Arredondo-Gálvez CG; Acuña-González D; Cantú-de-León D; Chanona-Vilchis JG; Avilés-Salas A; González-Enciso A; Bandala-Jaques A; Barquet-Muñoz SA
    Gynecol Obstet Invest; 2021; 86(3):293-298. PubMed ID: 34111875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
    Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
    Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery.
    Mousavi A; Modarres Gilani M; Akhavan S; Sheikh Hasani S; Alipour A; Gholami H
    Iran J Med Sci; 2021 Sep; 46(5):355-363. PubMed ID: 34539010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.